Gunnar Schulte

Gunnar Schulte

Professor | Docent
Telephone: +46852487933
Visiting address: Solnavägen 9, Biomedicum, 17165 Solna
Postal address: C3 Fysiologi och farmakologi, C3 FyFa Receptorbiologi, 171 77 Stockholm

About me

  • Gunnar Schulte is Professor in receptor pharmacology and research group leader for the section Receptor Biology and Signaling at the Department of Physiology and Pharmacology. He has a background in biochemistry from the Free University in Berlin/Germany and a PhD in molecular pharmacology (supervisor: Bertil B Fredholm) from Karolinska Institutet. As postdoc he trained first with Ernest Arenas (Karolinska Institutet, Molecular Neurobiology) and later with Roger J Summers (Monash University, Melbourna Australia, GPCR pharmacology) before starting his independent research team "Receptor Biology &
  • Signalling". Gunnar Schulte is also the scientific secretary of the Swedish Society for Medical Research (SSMF) and member on the editorial board/editorial advisory board of Molecular Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry.

    Diploma (biochemistry) - Free University of Berlin, Germany (1992-1998)
    PhD (Molecular Pharmacology) - Karolinska Institutet (1998-2002)
    Postdoc (Molecular Neurobiology) - Karolinska Institutet (2003-2005)
    Postdoc (Molecular Pharmacology - Monash University, Melbourna, Australia (2006)
    Junior Researcher (Receptor Biology &
  • Signaling) - Karolinska Institutet (2007-2014)
    Senior Researcher (Receptor Biology &
  • Signaling) - Karolinska Institutet (2015-2016)
    Professor (Receptor Pharmacology - Karolinska Institutet (2017-)


  • General Research Interest: Frizzled signaling and pharmacology and the role of WNT/Frizzled signaling in biology, physiology and disease. Most importantly my research team tries to understand underlying mechanisms of WNT-receptor interaction, relevance of receptor dynamics and receptor complex composition and specification of downstream signaling. The ultimate aim is to use the new knowlegde to find and create Frizzled-targeting drugs to improve future therapies of human disease.


All other publications



  • Professor, Department of Physiology and Pharmacology, Karolinska Institutet, 2017-

Degrees and Education

  • Docent, Karolinska Institutet, 2008
  • Doctor Of Philosophy, Department of Physiology and Pharmacology, Karolinska Institutet, 2002

News from KI

Events from KI